🎉 Finosauras is now  SarasRead more
Natco Pharma Ltd logo

Natco Pharma Ltd - Share Price Target 2026

(NSE: NATCOPHARM)

Sector: Healthcare

Market Cap: 14201.62 Cr

925.60

-

857.55

Target Price Range

933.60

-15.65 (-1.68%)

CMP

Bearish

As on 5 Dec 2025, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish1
Bearish3
Neutral2
Agg. Profit Potential18.95%
Agg. Risk 0.00%

Last updated on: 06/12/2025, 3:30 pm

Returns

PeriodReturn %
1 Month-0.98
3 Months9.02
1 Year-39.84
5 Years27.22

Last updated on: 06/09/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
BELGRAVE INVESTMENT FUND2.31%4,145,000
Life Insurance Corporation of India2.29%4,094,093
TATA MUTUAL FUND- TATA VALUE FUND1.2%2,156,471

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

8.46

P/B Ratio

1.82

PEG Ratio

0.19

ROE

28.63%

EPS

93.70

Dividend Yield

0.76%

Market Cap

14201.62 Cr

Sector

N/A

Last Updated: 13 Nov 2025, 01:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Natco Pharma Ltd.

Incorporated Year

1981

City and State

Hyderabad, Telangana

Listing Date

Director's Name

Vijayabhaskar Dronadula

Revenue

42350.00 Cr

Net Profit

22260.00 Cr